RAD51 and cancer: Loss of RAD51 upon MEKi was further confirmed in all CRC cell lines and three cancer organoids lines by immunoblot, showing a dose-dependent decrease of RAD51, both in the presence and absence of radiation (Figures 4E, 4F, S10A, and S10B).